Mahajan Imaging & Labs, a prominent name in imaging and diagnostic services, has unveiled a cutting-edge Dual Energy Spectral CT scanner at their Gurugram facility. This advanced CT scanner boasts remarkable technology, including an impressive rotation speed of just 0.3 seconds, allowing for rapid scanning without sacrificing image quality.
A significant advantage for patients is its reduced radiation exposure. Utilizing ultra-low-dose protocols, the scanner is ideal for preventive cardiac screenings and pediatric imaging, thereby minimizing radiation risk.
The system also incorporates AI-powered software, which enhances early disease detection, particularly for cardiac conditions. It can cut radiation doses for cardiac patients by up to 85%, making it safer for those undergoing heart-related evaluations. The Dual-Energy CT scanner provides high-definition, spectral analysis of body tissues and diseases, improving lesion characterization and tissue analysis non-invasively.
Dr. Harsh Mahajan, founder and chief radiologist at Mahajan Imaging & Labs, remarked, “Our new dual-energy spectral CT scanner transforms the scanning process, reducing scan times to mere seconds and delivering ultra-thin slices that enhance spatial resolution. The significantly lower radiation dose is especially beneficial for frequent CT scans and for children. With AI integration, this technology helps doctors detect heart diseases early and with greater accuracy. Building on the success of our Centre of Excellence for Integrated Diagnostics in Delhi, we are excited to bring these advanced services to Gurugram, improving diagnostic precision and treatment outcomes for patients in Haryana.”
Dr. Shelly Mahajan, lab director and clinical lead added, “The introduction of the Dual Energy Spectral CT scanner aligns with our vision of integrated diagnostics. We now offer comprehensive imaging, blood tests, and genomics services to Gurugram residents. For cancer patients, the scanner includes advanced oncology tracking features to monitor and analyze tumors over time. It also supports advanced CT-guided procedures, such as biopsies and FNACs, aiding in accurate diagnosis and treatment evaluation.”
As reported by pharmabiz.com, in addition to routine clinical imaging and diagnostics, Mahajan Imaging & Labs engages in advanced clinical and applied research in collaboration with prestigious institutions such as MIT, Max Planck Institute, AIIMS New Delhi, IIT Delhi, and leading global pharmaceutical and device manufacturers.